Related Experiment Video
Updated: Nov 2, 2025
04:54
Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
Published on: March 19, 2021
4.8K
Comparing Two Commercially Available Diabetes Apps to Explore Challenges in User Engagement: Randomized Controlled
Alita Maharaj1, David Lim1, Rinki Murphy2
1Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
JMIR Formative Research
|June 16, 2021
Summary
This study found low user engagement with diabetes apps like Glucose Buddy and mySugr, highlighting challenges in self-management technology. More clinical support and user-centered design are needed for effective diabetes app interventions.
Area of Science:
- Digital Health
- Behavioral Science
- Clinical Trials
Background:
- Diabetes self-management interventions can be resource-intensive.
- Mobile health (mHealth) apps offer a scalable alternative for diabetes care.
- Few studies have assessed diabetes apps as standalone interventions.
Purpose of the Study:
- To evaluate user engagement with two diabetes apps (Glucose Buddy, mySugr) in adults with type 2 diabetes.
- To assess the feasibility of a randomized trial for diabetes app interventions.
- To explore associations between app engagement, self-care behaviors, and illness beliefs.
Main Methods:
- Feasibility randomized trial comparing Glucose Buddy and mySugr over two weeks.
- Recruitment, adherence, and follow-up rates assessed for feasibility.
- User engagement, self-care behaviors, and illness beliefs measured post-intervention.
Main Results:
- Low user engagement observed in both app groups (median 4-6.5 days of use).
- No significant changes in self-care behaviors or illness beliefs were detected.
- Interviews indicated apps were acceptable but perceived as time-consuming and complex.
Conclusions:
- Low engagement with current diabetes apps presents a significant challenge for self-management.
- Future diabetes app development requires enhanced clinical support and user-centered design.
- Incorporating evidence-based behavior change techniques is crucial for app efficacy.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
648
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
648
01:22Diabetes Mellitus: Type 2 and Gestational
3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K